Try our Advanced Search for more refined results

May 23, 2013

Gilead Sciences, Inc. v. Natco Pharma Limited

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 14, 2014

    BIO, PhRMA Ask Fed. Circ. To Revisit Double-Patent Ruling

    Biotechnology Industry Organization and The Pharmaceutical Research and Manufacturers of America have told the Federal Circuit that its recent decision in a lawsuit over flu drug Tamiflu expanded the double-patent doctrine at a time that the doctrine is increasingly irrelevant because of changes in federal patent laws.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!